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Abstract: A novel qualitative point-of-care test of activated matrix metalloproteinase-8 (aMMP-8)
using noninvasive oral rinse sampling procedures has been developed for the early detection of
collagen breakdown indicating periodontal tissue destruction. The main object of this study was
to assess the reliability of the test in a low-income setting to identify participants with history of
periodontal destruction detected as alveolar bone loss (ABL) in radiographs. This cross-sectional
study included 486 women who had recently delivered in rural Malawi. The aMMP-8 test and
dental panoramic radiographs were taken within 48 h of delivery. The performance of the test
in comparison to radiological examinations was tested by following the standards for reporting of
diagnostic accuracy studies protocol (STARD) with respective statistical measures and 95% confidence
intervals. From the 486 eligible participants, 461 mothers with complete data, aged from 15 to 46 years
(mean 24.8, SD 6.0) were included in the analysis. ABL was identified in 116 of 461 participants. There
was 56% agreement between the aMMP-8 test results and detected ABL (yes or no) in radiographs.
Calculated sensitivity of the test was 80% (72–87%), specificity 48% (43–54%), positive predictive value
34% (31–37%), negative predictive value 88% (83–91%), positive likelihood ratio 1.55 (1.35–1.77), and
negative likelihood ratio 0.41(0.28–0.60). The aMMP-8 test sensitivity and negative predictive value
to identify the ABL cases were relatively high, but there was additionally a high rate of test-positive
results in participants without ABL, especially in young mothers, leading to low overall agreement
between the test results and radiological bone loss. Further longitudinal studies are needed to
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examine if the test positive subjects are in risk of future bone loss before the detectable signs of
periodontitis in radiographs.
Keywords: alveolar bone loss; matrix metalloproteinase (MMP)-8; periapical infection; periodontitis;
point-of-care testing; saliva
1. Introduction
Severe periodontitis, a destructive inflammatory condition of the tooth supportive tissues, is the
sixth most prevalent disease globally, affecting approximately 11% of the population [1]. It has been
estimated that in addition to enormous direct treatment costs, severe periodontitis causes productivity
loss worth 54 billion US$ globally every year [2]. However, treatment of periodontitis is relatively
simple and cost-effective if diagnosed at its early stages. Challenging enough, periodontitis is usually
asymptomatic, i.e., a person who has the disease is not aware of it, and its traditional diagnostics
require highly skilled dental professionals and equipment that are often not available, particularly in
resource-poor settings [2–4].
A newly developed point-of-care test to diagnose periodontitis using mouth rinse, known as the
aMMP-8 test, has recently been launched and a few validating studies documenting good diagnostic
accuracy of the test are already available [5–11]. The test resembles a pregnancy test and it is easy to use.
aMMP-8 test diagnostics are based on active matrix-metalloproteinase-8 (aMMP-8) level analysis by
lateral flow immunoassay in mouth rinse and it provides information about the inflammatory burden
of the periodontium [5,6,9,12–14]. In a previous study, aMMP-8 test differentiated adolescent patients
having gingivitis or initial periodontitis from healthy participants with a good accuracy according to
prior radiographic manifestations [5–10]. In addition, the positive test result was associated with the
candidate susceptibility genes of periodontitis [6].
A main biological function of MMP-8 in the periodontium is to facilitate leukocyte, especially
neutrophil granulocyte, migration from the circulation toward the periodontal sulcus by cleaving
collagens and other extracellular matrix components [15]. In addition, other cell types (e.g., fibroblasts)
can express MMP-8 after induction of inflammatory signals [16,17]. Abundant and noncontrolled
MMP-8 expression, release, and activation together with other MMPs and proteinases are considered to
cause inflammation-related tissue destruction in periodontitis and in other inflammatory diseases [13].
MMP-8 activation is facilitated by other MMPs and host-derived proteases and oxidative burst
caused mainly by myeloperoxidase (MPO) released from neutrophils [18]. Bacteria-derived proteases,
from, e.g., Porphyromonas gingivalis (gingipains) and Treponema denticola, can also activate MMPs [18].
Thus, the innovation from the diagnostic point of view is not to measure the total concentration
of MMP-8 per se, but the active isoform of the enzyme [13,18]. The monoclonal antibody utilized
in the aMMP-8–test is developed to target aMMP-8 indicating the vicious circle of the destructive
inflammation process [13,17,18].
In a real-life situation, sources of oral inflammation and aMMP-8 are not restricted to periodontitis.
In addition to periodontitis, the test might be able to detect periapical lesions (PAL) [13,19]. Periapical
inflammation develops from endodontic infection, most commonly caused by deep caries lesions, and
shares some etiopathogenic mechanisms with periodontitis. A recent study demonstrated that apical
lesions can also modify the composition of oral fluids and can be acutely diagnosed through MMP-8
assessment in gingival crevicular fluid (GCF) [19].
This study is a part of larger MiTeeth study focused on assessment of maternal periapical infections
and their association with infant birth size in a rural Malawian population. Maternal periapical
infections were associated with a shorter pregnancy duration and intrauterine growth restriction
in a previous study within the Malawian population [20]. Interestingly, the association was not
found between periodontitis and the pregnancy outcomes, respectively [20]. The MiTeeth study
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was designed to obtain confirmation for the previous results within a different study sample from
same area of Malawi. Coprevalence of periodontitis and periapical infections is common in this
population [20], being also a challenge for study design and statistical analysis to extract interacting
effects of periapical lesions and periodontitis exposure on the pregnancy outcomes. aMMP-8 tests were
taken to gain information about the oral inflammatory burden and to complete radiological diagnosis
of periapical lesions and periodontitis in a low-resource setting where clinical examination was not
possible to conduct.
The aim of this presented study (a substudy of the larger MiTeeth study) was to assess the
screening utility of the aMMP-8 test. The diagnosis of periodontitis is based on full-mouth continuous
periodontal probing with a manual probe and detailed recording of clinical attachment levels,
probing depths, visual plaque, and bleeding on probing from six sites of every tooth. The current
golden standard method for screening periodontitis is clinical initial examination and determination
of different periodontal screening indices (periodontal screening index (PSI) (in Germany) and
periodontal screening and recording—PSR® (established by the American Dental Association and
the American Periodontal Association in 1992), which are derivatives of the community periodontal
index (CPI) [21]. These indices are based on periodontal probing of every tooth at four sites. A site
with the most severe disease defines the value of the index, and the index values are determined
for each sextant of dental arch, making the procedure slightly faster in comparison to making the
actual diagnosis [21–24]. In this study, periodontal probing was not possible to conduct and the testing
of screening performance was done by comparing the aMMP-8 test with radiological diagnosis of
alveolar bone loss indicating history of periodontitis. History of periodontitis is a known risk factor for
future disease progression [25,26]. However, previous studies have found that the agreement between
probing indices and radiological findings has not been very high [22,24]. The second aim was to study
association between ABL, PAL, and the test results. To the best of our knowledge, this is the first study
in which both ABL and PAL are taken into account when oral rinse aMMP-8 levels are studied.
The study hypotheses were that aMMP-8 test results associate with ABL and possibly with
PAL and that the test can differentiate the ABL cases. The respective null hypotheses were: (i) the
aMMP-8 test cannot differentiate participants with and without ABL and (ii) aMMP-8 test results are
not associated with ABL and PAL.
2. Results
2.1. Patient Characteristics of Included and Excluded Participants
Participants who had both the periodontitis rapid test and dental panoramic radiograph results
available were included in the present analysis (n = 486). There were 25 mothers whose self-reported
age was not known and were thus excluded from the regression analyses adjusted by maternal
age and age stratifications. Participants characteristics for the included (n = 461) and excluded
(n = 25) participants are described in Table 1. Body mass index (BMI), C-reactive protein (CRP), and
haemoglobin (Hb) levels were measured to monitor maternal physiological condition after delivery.
Thirty percent of mothers had CRP above the threshold of 40 mg/L, indicating bacterial infection.
There were no significant differences between groups of included and excluded participants in CRP,
BMI, or Hb levels. However, the frequency of human immunodeficiency virus (HIV) positivity and the
prevalence of missing teeth and caries were slightly more common in the participants excluded due to
the missing age information (Table 1).
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Table 1. Characteristics of included and excluded participants.
Patient Characteristics
Included (n = 461) Excluded (n = 25)
Mean (95% CI)/Count (%) Mean (95% CI)/Count (%)
General Health Characteristics
Mother Age (years, self-reported) 24.8 (24.2–25.3) -
BMI (kg/m2) 23.2 (22.9–23.5) 22.3 (21.1–23.4)
CRP (mg/L) 33.5 (31.0–36.0) 41.9 (25.2–58.6)
CRP above 40 mg/L 138 (30%) 8 (32%)
Haemoglobin Levels (g/L) 105 (103–106) 106 (98–114)
HIV test
Negative 411 (89%) 18 (72%)
Positive 48 (10%) 7 (28%)
Not Tested 2 (1%) 0
Malaria test
Negative 452 (98%) 25 (100%)
Positive 8 (1.7%) 0
Not Tested 1 (0.3%) 0
Oral Health Characteristics
Tooth Cleaning
(self-reported)
No daily basis cleaning 0 0
Once a day 28 (6%) 2 (8%)
Twice a day 433 (94%) 23 (92%)
Tooth Cleaning Method
(self-reported)
Finger 16 (3%) 2 (8%)
Toothbrush 445 (97%) 23 (92%)
aMMP-8 Test Results
Negative 189 (41%) 5 (20%)
Weak positive 192 (42%) 15 (60%)
Strong positive 80 (17%) 5 (20%)
Proportion of mothers with ABL (case) * 116 (25%) 8 (32%)
Proportion of mothers with caries 255 (55%) 19 (76%)
Proportion of mothers with PAL 127 (28%) 11 (44%)
Proportion of mothers with missing teeth 112 (24%) 11 (44%)
Body mass index (BMI); C-reactive protein (CRP); alveolar bone loss (ABL); periapical lesions (PAL); human
immunodeficiency virus (HIV). * The case definition was based on radiological marginal bone loss detection and
the case definition of Eke et al. [27] was modified to fit with radiological data.
2.2. Covariates/Cofactors of aMMP-8 Test Results
The potential covariates and cofactors of aMMP-8 test results are presented in Table 2. Maternal
age was statistically significantly associated (p < 0.05) with the test results. There were no significant
differences in CRP, BMI, or Hb levels, or in frequencies of HIV or malaria test results between
participants with different aMMP-8 test results. From all listed oral-health-related variables, only ABL
and PAL were significantly positively (p < 0.05) associated with aMMP-8 test results. The associations
between the test results and ABL/PAL were further analysed with the multivariate regression models.
2.3. The Association between aMMP-8 Test Results and ABL and PAL
There was a statistically significant association between aMMP-8 test results and the extent of
ABL and maternal age analysed with the generalized linear regression modelling (GLM). Results
from the statistical model are given in Table 3. The positive test results (strong or weak) indicated
approximately three times (strong positives, 3.5 teeth, 95% confidence interval (CI) 2.7–4.4), and two
times (weak positives, 2.5 teeth, 95% CI 2.1–3.0) higher numbers of teeth with ABL compared with the
negative test (1.2 teeth, 95% CI 1.0–1.5), when the model was adjusted by the fixed mean age of the
mothers (24.8 years) (Table 3).
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Table 2. Potential covariates of aMMP-8 test results and alveolar bone loss.
Potential Covariates/
Cofactors of aMMP-8 Test
aMMP-8 Test Results
Negative
(n = 189)
Weak Positive
(n = 192)
Strong Positive
(n = 80)
Mean (95%
CI)/Count (%)
Mean (95% CI)/
Count (%)
Mean (95% CI)/
Count (%)
General health-related variables
Age (years, self-reported) 24 (23–25) 25 (24–26) 27 (25–28)
Haemoglobin (g/L) 105 (102–108) 103 (101–106) 106 (101–110)
BMI (kg/m2) 23.5 (23–24) 22.9 (22.5–23.3) 23.1 (22.3–23.8)
CRP (mg/L) 34.3 (30–38.5) 34.6 (30.8–38.3) 29 (24.3–33.7)
HIV
Positive 15 (8%) 24 (13%) 9 (11%)
Negative 173 (92%) 168 (87%) 70 (88%)
Not tested 1 (0.5%) 0 1 (1%)
Malaria
Positive 3 (1.5%) 5 (3%) 0
Negative 185 (98%) 187 (97%) 80 (100%)
Not tested 1 (0·5%) 0 0
Oral-health-related variables
Tooth cleaning twice a day
(self-reported) 178 (94%) 186 (97%) 69 (86%)
Tooth Cleaning Method
(self-reported)
Finger 5 (3%) 4 (2%) 7 (9%)
Toothbrush 184 (97%) 188 (98%) 73 (91%)
Number of teeth with ABL 1.4 (1.0–1.8) 3.0 (2.4–3.6) 4.9 (3.7–6.2)
Proportion of mothers with ABL (case) 23 (12%) 58 (30%) 35 (44%)
Number of teeth with caries 1.6(1.3–1.9)
2.2
(1.8–2–7)
1.9
(1–3–2–4)
Proportion of mothers with caries 96 (51%) 114 (59%) 45 (56%)
Number of teeth with PAL 0.4(0.2–0.5)
0.6
(0.5–0.8)
0.7
(0.4–0.9)
Proportion of mothers with PAL 43 (23%) 55 (29%) 29 (36%)
Number of missing teeth 0.4(0.3–0.5)
0.6
(0.4–0.8)
0.7
(0.3–1.0)
Proportion of mothers with missing teeth 45 (24%) 43 (22%) 24 (30%)
Table 3. Association between aMMP-8 test results and marginal alveolar bone loss or periapical lesions.
Outcome Models *
aMMP-8 Test Results
Negative
(n = 189)
Weak Positive
(n = 192)
Strong Positive
(n = 80)
p-Value
(Test of Model Effects)
Number of
teeth with ABL
Adjusted marginal means 1.3(1.0–1.5) 2.5 (2.1–3.0) 3.5 (2.7–4.4) <0.001
Pairwise comparison (mean difference) - 1.3 (0.7–1.9) 2.2 (1.1–3.3)
p-value(pairwise comparison) - <0.001 <0.001
Number of
teeth with PAL
Adjusted marginal means 0.3(0.3–0.5) 0.6 (0.5–0.7) 0.5 (0.4–0.8) <0.05
Pairwise comparison
(mean difference) - 0.2 (0.0–0.4) 0.2 (−0.1–0.5)
p-value
(pairwise comparison) - <0.05 >0.05
Alveolar bone loss (ABL), periapical lesion (PAL); * Models are adjusted by fixed estimate of mean mother age:
24.8 years.
The extent of PAL exhibited covariation with ABL in this data and is a potential modifier of
aMMP-8 test results. The extent of PAL was significantly associated with the test results after the
adjustment by age, but there were controversies in the pairwise comparisons: the weak positive test
results associated significantly with the extent of PAL (p < 0.05), but the strong positives did not
(p > 0.05) (Table 3).
The association of ABL and PAL with the aMMP-8 test result was further explored with the
logistic regression model, in which the test result was the outcome measure and detected radiological
findings of ABL and/or PAL was the explaining factor adjusted by the maternal age as the covariate.
ABL alone (p < 0.05) or the combination of ABL and PAL (p < 0.001) associated significantly with the
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positive test results, but PAL alone did not associate with the positive results (Table 4). Maternal age
was a confounder associating with ABL and PAL in the GLM described above, but could not explain
significantly the test results in the logistic model, implying that age did not have any independent
effect on MMP-8 levels.
Table 4. Logistic regression model on association between the radiological findings and aMMP-8 test
results adjusted by mother age.
Outcome: aMMP-8 Test Result * Adjusted Model (n = 461)
Explaining factors and covariates Odds ratio (95% CI) p-Value
Radiological finding No ABL or PAL(n = 270) 1 (ref) <0.001
ABL but no PAL
(n = 64) 2.7 (1.4–5.1) <0.05
PAL but no ABL
(n = 75) 0.98 (0.59–1.7) Ns
Both ABL and PAL
(n = 52) 5.7 (2.4–13.4) <0.001
Mother age 1.00 (0.99–1.01) Ns
Alveolar bone loss (ABL), periapical lesion (PAL), statistically nonsignificant (ns); * Outcome: Dichotomous aMMP-8
test result (negative vs. positive, both weak and strong).
2.4. Screening Utility of the aMMP-8 Test for Alveolar Bone Loss Cases
The screening utility of the aMMP-8 test to identify ABL cases referring to history of periodontitis
was analysed by cross-tabulating the test results (negative or positive) and the dichotomous ABL-case
variable (Table 5). The sensitivity of the test in the whole study population was 80% and specificity
was 48%. Respectively, positive predictive values (PPV), i.e., rate of true positives from all positives,
and negative predictive values (NPV), rate of true negatives, were 34% and 88%. Furthermore, the
overall agreement of test results with the ABL cases, with at least two teeth with mild or more severe
bone loss in radiographs, was 56%.
Table 5. Cross tabulation of aMMP-8 test results and the dichotomous ABL-case variable.
aMMP-8 Test
Age
Group
ABL
Case
Negative Positive Measures of Diagnostic Screening Utility
Count Count Sens. Spec. PPV NPV LR+ LR– Accuracy
15–24
years
No 114 111
Yes 8 27 77(60–90)%
51
(44–57)%
20
(16–23)%
93
(88–96)%
1.56
(1.25–1.96)
0.45
(0.24–0.84) 54%
25–34
years
No 42 63
Yes 10 43 81(68–91)%
40
(31–50)%
41
(36–46)%
81
(70–89)%
1.35
(1.10–1.66)
0.47
(0·26–0.86) 54%
35–46
years
No 10 5
Yes 5 23 82(63–94)%
67
(38–88)%
82
(69–91)%
67
(46–83)%
2.46
(1.18–5.15)
0.27
(0.11–0.64) 77%
Total
No 166 179
Yes 23 93 80(72–87)%
48
(42–54)%
34
(31–37)%
88
(83–91)%
1.55
(1.35–1.77)
0.41
(0.28–0.60) 56%
Alveolar bone loss (ABL), sensitivity (sens.), specificity (spec.), positive predictive value (PPV), negative predictive
value (NPV), positive likelihood ratio (LR+), negative likelihood ratio (LR−).
Respective measures were calculated also separately for stratified age groups: PPV ranged from
20% in the youngest age group up to 82% in the oldest group as the measures of NPV ranged from
93% to 67%, respectively. Sensitivity rates varied from 77% to 82% and specificity from 40% to 67% by
the age groups. The agreement of the test results was from 54% among the youngest age group and in
the group of 25–34-year-olds up to 77% in the group of the oldest mothers.
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The proportion of participants (crude prevalence) with the positive periodontitis screening result
(aMMP-8 test-positive or radiological ABL case) was described further in smaller age groups with
five-year intervals (Figure 1).
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Figure 1. Proportion (%) of patients with aMMP-8 test positive result or ABL detected in radiographs.
The proportion of aMMP-8 test positives is higher in young participants when compared to ABL.
The proportion of aMMP-8 test positives increased from 43% in the youngest age group
(15–19 years) up to 68% by the age of 25–29 years, being approximately the same in the older age
groups (30–34, 35–39, and 40–46 years). In comparison, the proportion of radiological ABL cases
increased from 7% in the youngest group up to 75% in the oldest participants (40–46 years old).
3. Discussion
Our study d monstrated the association between aMMP-8 test results and the exte t of ABL
in radiographs. There was no significant a sociation between PAL and th test results if ABL and
maternal age were taken into account in t e statistical mod ls, supporti g the rejection of the null
hypothesis related to ABL, but not to PAL. The test was sensitive enough to identify participants with
ABL, but there was also a high rate of participants with positive test results, especially among the
young participants, but no detectable ABL in radiographs, leading to a low overall agreement between
the test results and the ABL cases, giving support for the first null hypothesis.
A weakness/limitation of this study is the lack of clinical periodontal data (periodontal probing
measures). This topic is discussed with more detailed below. Another weakness is the unclear validity
of self-reported or missing mat rnal age information. Strengths of the study inclu e th large study
sample size, comprehensive data collection methods, and compl teness of th data.
Data stratification and the subgr up analysis revealed that the test agreement differed by
participants′ age. Among younger mothers (from 15 to 34 years), the overall agreement was low,
at around 50%, because of the large proportion of “false positive” results, i.e., positive test results
without the bone loss in radiographs. In comparison, the agreement was 77% in the group of the
oldest mothers (35–46 years), which is in line with previous validating studies with Finnish, German,
Nigerian, and U.S. populations [5–11]. Because the lack of clinical periodontal probing measures, that
would have enabled the detection of healthy, gingivitis, and initial periodontitis cases more accurately
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compared to X-ray data, it is not known if these young “false positive” mothers were true “false
positives”, i.e., without bone loss and any periodontal inflammation, or actual “true positives” without
bone loss but with significant periodontal inflammation with a risk of future bone loss. It is well known
that radiographic findings of periodontal disease develop slowly, while the clinical signs are detectable
earlier [22,24,28]. Ziebolz et al. compared PSI results to radiological diagnosis of periodontitis in dental
panoramic X-rays. They found that in 47% of cases, the diagnosis was not converging, which is in line
with our results. The proportion of aMMP-8 test positives reached the peak levels of 60–70% in five
to ten years’ younger participants (25–29 years old) in comparison to the proportion of radiographic
ABL cases (35–39 years old), suggesting that the test positivity eventually appears prior to bone loss.
In fact, the test positivity could identify and reflect gingivitis and alert to so-called pre-periodontitis
in participants without detectable ABL, thus making it more sensitive than identification based on
radiographs solely, a finding also supported by previous studies [6,7,11].
It is also good to keep in mind that the closest clinical index corresponding to the aMMP-8
test is bleeding on probing (BOP). BOP is the golden standard to indicate the presence of active
periodontal disease at the site and patient level [29,30]. Nevertheless, the BOP measurement is
exposed to a subjective estimation of the clinician, and the oral fluid aMMP-8 detection could be
seen in a more objective way to define the amount of inflammation in oral fluids. It has also been
shown that the elevated levels of aMMP-8 in oral fluids precede and reflect future active periodontal
degeneration [18,31,32]. However, further longitudinal studies are needed to examine if the test-positive
subjects are at risk of future ABL before the detectable signs of periodontitis in radiographs and clinical
outcomes arise.
There are not many epidemiological studies available describing the prevalence of periodontitis
in the Malawian population [33]. A systematic review of the global burden of severe periodontitis in
1990–2010 gave an estimate of severe periodontitis prevalence to be 20.1% (9.2–35.9%) in Malawi [34]. In
the review study, case definitions and inclusion criteria for severe periodontitis were based on clinically
determined periodontal probing measures and periodontal indices, in comparison to radiographs and
the aMMP-8 test in this study. In the present study, the ABL case definition included not only severe
cases, but all cases, from mild localized to generalized severe alveolar bone loss [20]. It is also good to
keep in mind that the present study was focused on the specific group of participants (relatively young
females), excluding some risk groups of periodontitis (e.g., smokers, males). Thus, it is reasonable to
assume that the prevalence of periodontitis was lower in the present study compared to the respective
whole population in Mangochi district, Malawi. In an earlier study among a similar female Malawian
(Mangochi district) population by Harjunmaa et al., the overall periodontitis prevalence was 31.9%,
which is noticeably higher than in this study [21]. The difference is mostly explained by different
diagnostic methods used in the earlier study based on both clinical and radiographic findings [21]. The
previous study included also participants from more rural areas of Malawi, with higher prevalence of
infections in comparison to people in the Mangochi area.
In this study, a significant proportion of participants were HIV-positive. HIV has been associated
with periodontitis, and in theory, it could also have a modifying effect on MMP-8 levels [35].
All included HIV-positive participants had ongoing HIV medication in the present study. There were
no significant associations observed between aMMP-8 and HIV test results in the descriptive analysis.
Oral inflammatory diseases such as marginal and periapical periodontitis share similar risk factors
and forms with a genetically related cluster of patients also presenting systemic proinflammatory
pathological manifestations such as cardiovascular diseases, stroke, diabetes, and adverse pregnancy
outcomes [20,36–39]. Despite the widely reported associations between oral inflammatory diseases and
systemic pathological conditions, it is not well-known whether oral inflammatory diseases are actual
true risk factors of systemic diseases and what is the quality, extent, and severity of inflammation that
matters if oral diseases are screened as a risk factor or marker in the perspective of systemic diseases.
Whether it is an inflammatory burden indicated by a test such as the aMMP-8 test or a specific stage of
periodontal/periapical disease defined by clinical/radiological examination, is an important question
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to answer in further studies, and addressed also by the MiTeeth research project (data not analyzed
and published yet).
We conclude that the aMMP-8 test results correlate with the extent of alveolar bone loss in
radiographs, but the overall agreement between aMMP-8 test results and the alveolar bone loss cases
was low. Especially in young mothers, a significant proportion of participants had positive aMMP-8
test results without the bone loss. Further studies are needed to examine if the test-positive subjects
without the bone loss have significant inflammation around periodontal tissues, explaining the positive
results, and are at risk of future bone loss before the detectable signs of periodontitis in radiographs.
4. Materials and Methods
4.1. Design, Study Site, Participants, and Enrolment
This was a cross-sectional study, in which the utility of an oral rinse-based novel rapid point of
care (POC) test for periodontitis to identify participants with radiographically detected ABL and PAL
was evaluated.
This research is a substudy of a larger MiTeeth study that aimed to investigate the association
between maternal oral health and infant birth size in rural Malawi, Southern Africa. Mothers who had
given birth within 48 h were enrolled at the Mangochi District Hospital postnatal ward between April
2016 and October 2016. Participants for the present substudy were recruited between May and August
2016. Mangochi District Hospital serves an estimated population of 100,000. The district hospital
catchment area is semiurban and it is serviced by all-weather roads. The population is mostly Chi-Yao
speaking and subsists largely on farming and fishing. Malaria infection is endemic with seasonal
fluctuations. Health services are provided through public facilities and are free at point of delivery.
In this rural African population, oral infections are common, but except for tooth extractions, very
little dental treatment is available.
Eligible participants were identified at the hospital postnatal ward. Women were briefed about
the purpose of the study and its procedures and those wishing to participate went through an
eligibility assessment. The inclusion criteria were: delivered a live infant at the hospital and signed or
thumb-printed informed consent. The exclusion criteria were: age less than 15 years of age, multiple
pregnancy, postnatal or maternal death prior to the data collection, full data cannot be collected due
to the poor health condition of the mother or the infant, congenital malformation of the infant, data
collected later than 48 h after delivery, regular smoker, participation in an intervention study during
the pregnancy. Participant flow is described as detailed in Figure 2.
4.2. Data Collection
The data collection was conducted at one visit within 48 h after delivery at the hospital postnatal
ward and at the study clinic next to it. A study nurse interviewed the participants on their health
history and relevant background information. Then, the periodontitis aMMP-8 POC test (PerioSafe®
PRO, Dentognostics GmbH, Jena, Germany) was performed in accordance to the manufacturer’s
instructions. The test results were visually evaluated to be strong positive (++), weak positive (+),
and negative (−), according the prespecified cutoff values of the test (example cases presented in
Figure 3) [3].
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After that, the nurse collected a finger prick blood test from the mother to diagnose C-reactive
protein (CRP) and hemoglobin (Hb) concentrations and malaria status by rapid tests, and analysed
them at the study site using test kits (QuickRead Go CRP + Hb, Orion Diagnostica, Espoo, Finland;
Clearview® Malaria Combo, Alere Inc, USA). The study nurse collected also information on the
participants’ HIV status and treatment from the hospital records, or if missing, by asking the mother.
An anthropometrist measured the length, weight, and mid-upper arm circumference (MUAC) of the
mother. A dental therapist or a trained assistant conducted a structured interview on the oral health
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history of the mother and took a digital panoramic radiograph of her teeth and jaws (Planmega Proline
XC, Planmeca, Finland).
An oral and maxillofacial radiologist (J.J.) and an experienced dentist (U.H.) blindly analysed the
radiographs using digital imaging software (Planmega RomexisTM, Planmeca, Finland) at Tampere
University Hospital Medical Imaging Center, Tampere, Finland. They recorded the number of teeth,
caries lesions extending to the dentine or pulp, PAL, and marginal alveolar bone level at each tooth
from the dentinoenamel junction to the bone margin, relative to the full root length (normal, initial,
cervical, middle, or apical third) using structured forms. Initial ABL was determined as detectable
“initial” signs without significant horizontal bone loss or vertical pockets in the radiological diagnosis.
4.3. Ethics
Written or thumb-printed informed consent was taken from the participants at enrolment. Ethical
approval was obtained from the College of Medicine Research and Ethics Committee, University
of Malawi (No. P.09/15/1797), and the Ethics Committee of Pirkanmaa Hospital District, Finland
(No. R16044, 3/2016). We enrolled only participants who signed or thumb-printed an informed consent.
Participants who had dental diseases were provided complimentary dental treatment at Mangochi
District Hospital dental clinic with resources provided by the research group.
4.4. Statistical Methods
4.4.1. Descriptive Analysis of Study Population and Variable Definitions in Statistical Analysis
Different variables describing general (CRP, Hb, BMI, HIV, malaria) and oral health characteristics
(self-reported oral hygiene behaviour, proportion of participants with ABL cases, caries, PAL, and
missing teeth) of included (n = 461) and excluded participants (n = 25), and also aMMP-8 test result
groups, were compared in tables by reporting means and 95% confidence intervals of continuous/count
variables or, in the case of categorical (nominal) variables, the number of participants in each category
and percentage proportion of it.
The number of teeth with ABL (initial, mild, moderate, or severe), PAL, caries, and missing
teeth as ordinal count variables were used to describe the extent of different radiological findings.
Categorical variables of ABL, PAL, caries, and missing teeth cases were used to report proportions of
participants with the respective findings. The case definition for categorical variables was at least one
tooth with the respective radiological finding, except for the ABL case. The ABL case definition was
based on ABL extent and severity and was modified from the Eke et al. periodontitis case definition
based on attachment loss measures [27]. The ABL case inclusion criterion was at least two teeth with
mild or more severe ABL. Thus, mothers with initial ABL or localized mild or more severe ABL around
only one tooth were not included into the ABL cases.
The used statistical units in the statistical analysis were the number of teeth in the analysis
of associations between the aMMP-8 test and ABL/PAL and the number of participants in logistic
regression analysis and the analysis of screening utility (see case definitions below).
4.4.2. Association between the aMMP-8 Test and Extent of ABL or PAL
ABL and PAL associate with each other and share common risk factors, e.g., oral hygiene
behaviour. They are both also strongly confounded by the age of the participant [40]. The association
between the aMMP-8 test and extent of ABL and PAL were analysed using generalized regression
modelling (GLM). The number of teeth with ABL (initial or more severe) or PAL was used as the
dependent outcome variable indicating the extent of ABL or PAL. The number of teeth with a positive
radiological finding was typical count data and was right-skewed. Negative binomial distribution with
the log link was the chosen model type for analyses. The aMMP-8 test result was the explaining factor
in the model. All regression models were adjusted by the participants’ age, the strong confounder of
both ABL and PAL. Bonferroni correction for multiple hypothesis testing was utilized when post-hoc
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pairwise comparisons were reported. The statistical significance of effect estimates in the regression
model and post-hoc pairwise comparisons were evaluated and reported with the p-value at 0.05 and
0.001 levels.
4.4.3. Relative Size of Association between the aMMP-8 test and ABL in Comparison to PAL
Because ABL and PAL associate with and are covariates of each other, an additional logistic
regression analysis was performed to analyse the relative size of the association between the aMMP-8
test result and ABL or PAL. In this analysis, dichotomous aMMP-8 test results, negative or positive
(both weak and strong), were set as the outcome measure and the detected radiological findings of
ABL and PAL were combined into a categorical (patient-level) explanatory variable in the model as
follows: first, participants with no ABL or PAL; second, participants with ABL only; third, participants
with PAL only; and fourth, participants with both ABL and PAL. The model was adjusted by the
maternal age as a covariate. The categorical ABL case definition for the above-described radiological
findings parameter was created, as described above, according to ABL extent and severity.
4.4.4. Screening Utility of the aMMP-8 Test to Correctly Identify Periodontitis Referring to ABL Cases
The utility of the aMMP-8 test to identify participants with ABL findings was studied by
cross-tabulating aMMP-8 test results and the ABL case variable. Sensitivity, specificity, positive
(PPV) and negative predictive values (NPV), positive (LR+) and negative likelihood ratios (LR−),
and the percentage of agreement between the test results and the ABL cases were reported by the
tabulation. Cross-tabulation and respective calculations were performed using the whole study
population and separately stratified by age groups (15–24, 25–34, 35–46 years). Age groups followed
general recommendations for age stratifications in periodontal epidemiological studies [41].
5. Patents
Timo Sorsa is an inventor of U.S. patents 5652223, 5736341, 5866432, and 6143476, and Timo Sorsa
and Dirk-Rolf Gieselmann are inventors of the WO 2015 128549 A-I patent, on the diagnostic use and
method of analysis of MMPs and their inhibitors in oral fluids.
Author Contributions: U.H., T.S., P.A., U.A., C.M., and J.J. conceived and designed the study. U.H. was
responsible for collecting the data. J.J. and U.H. interpreted the radiographs. J.M.L. analyzed the data. J.M.L. and
U.H. wrote the first draft of the paper. All authors made a substantial intellectual contribution and accepted the
final version of the manuscript, and met the criteria for authorship.
Acknowledgments: This study was financially supported by grants from the Helsinki University Central
Hospital Research Foundation (TYH 201625I, TYH 2017251, Y1149SUL32), Helsinki, Finland; the Karolinska
Institutet, Stockholm, Sweden; University of Tampere and the Competitive State Research Financing of the Expert
Responsibility area of Tampere University Hospital, Tampere, Finland; FONDECYT 1160741, Santiago, Chile.
Conflicts of Interest: All other authors except Timo Sorsa and Dirk-Rolf Gieselmann declare no conflicts of
interests. The conflicts of interests of these two authors are explained in the paragraph Patents.
References
1. Marcenes, W.; Kassebaum, N.J.; Bernabe, E.; Flaxman, A.; Naghavi, M.; Lopez, A.; Murray, C.J. Global burden
of oral conditions in 1990–2010: A systematic analysis. J. Dent. Res. 2013, 92, 592–597. [CrossRef] [PubMed]
2. Mohd Dom, T.N.; Ayob, R.; Abd Muttalib, K.; Aljunid, S.M. National economic burden associated with
management of periodontitis in Malaysia. Int. J. Dent. 2016, 2016, 1891074. [CrossRef] [PubMed]
3. Mohd-Dom, T.; Ayob, R.; Mohd-Nur, A.; Abdul-Manaf, M.R.; Ishak, N.; Abdul-Muttalib, K.; Aljunid, S.M.;
Ahmad-Yaziz, Y.; Abdul-Aziz, H.; Kasan, N.; et al. Cost analysis of periodontitis management in public
sector specialist dental clinics. BMC Oral Health 2014, 14, 56. [CrossRef] [PubMed]
4. Mohd-Dom, T.N.; Wan-Puteh, S.E.; Muhd-Nur, A.; Ayob, R.; Abdul-Manaf, M.R.; Abdul-Muttalib, K.;
Aljunid, S.M. Cost-effectiveness of periodontitis management in public sector specialist periodontal clinics:
A societal perspective research in Malaysia. Value Health Reg. Issues 2014, 3, 117–123. [CrossRef] [PubMed]
Diagnostics 2018, 8, 67 13 of 15
5. Heikkinen, A.M.; Nwhator, S.O.; Rathnayake, N.; Mantyla, P.; Vatanen, P.; Sorsa, T. Pilot study on oral
health status as assessed by an active matrix metalloproteinase-8 chairside mouthrinse test in adolescents.
J. Periodontol. 2016, 87, 36–40. [CrossRef] [PubMed]
6. Heikkinen, A.M.; Raivisto, T.; Kettunen, K.; Kovanen, L.; Haukka, J.; Esmaeili, E.P.; Elg, J.; Gieselmann, D.R.;
Rathnayake, N.; Ruokonen, H.; et al. Pilot study on the genetic background of an active matrix
metalloproteinase-8 test in finnish adolescents. J. Periodontol. 2017, 88, 464–472. [CrossRef] [PubMed]
7. Heikkinen, A.M.E.; Esmaeili, E.P.; Kovanen, L.; Ruokonen, H.; Kettunen, K.; Haukka, J.; Tervahartiala, T.;
Sorsa, T. Periodontal initial radiological findings of genetically predisposed finnish adolescents. J. Clin.
Diagn. Res. 2017, 11, ZC25. [CrossRef] [PubMed]
8. Lorenz, K.; Keller, T.; Noack, B.; Freitag, A.; Netuschil, L.; Hoffmann, T. Evaluation of a novel point-of-care
test for active matrix metalloproteinase-8: Agreement between qualitative and quantitative measurements
and relation to periodontal inflammation. J. Periodontal. Res. 2017, 52, 277–284. [CrossRef] [PubMed]
9. Nwhator, S.O.; Ayanbadejo, P.O.; Umeizudike, K.A.; Opeodu, O.I.; Agbelusi, G.A.; Olamijulo, J.A.;
Arowojolu, M.O.; Sorsa, T.; Babajide, B.S.; Opedun, D.O. Clinical correlates of a lateral-flow immunoassay
oral risk indicator. J. Periodontol. 2014, 85, 188–194. [CrossRef] [PubMed]
10. Izadi Borujeni, S.; Mayer, M.; Eickholz, P. Activated matrix metalloproteinase-8 in saliva as diagnostic test for
periodontal disease? A case-control study. Med. Microbiol. Immunol. 2015, 204, 665–672. [CrossRef] [PubMed]
11. Alassiri, S.; Parnanen, P.; Rathnayake, N.; Johannsen, G.; Heikkinen, A.M.; Lazzara, R.; van der Schoor, P.;
van der Schoor, J.G.; Tervahartiala, T.; Gieselmann, D.; et al. The ability of quantitative, specific, and sensitive
point-of-care/chair-side oral fluid immunotests for ammp-8 to detect periodontal and peri-implant diseases.
Dis. Markers 2018, 2018, 1306396. [CrossRef] [PubMed]
12. Leppilahti, J.M.; Ahonen, M.M.; Hernandez, M.; Munjal, S.; Netuschil, L.; Uitto, V.J.; Sorsa, T.; Mantyla, P.
Oral rinse mmp-8 point-of-care immuno test identifies patients with strong periodontal inflammatory burden.
Oral Dis. 2011, 17, 115–122. [CrossRef] [PubMed]
13. Sorsa, T.; Gursoy, U.K.; Nwhator, S.; Hernandez, M.; Tervahartiala, T.; Leppilahti, J.; Gursoy, M.; Kononen, E.;
Emingil, G.; Pussinen, P.J.; et al. Analysis of matrix metalloproteinases, especially mmp-8, in gingival
creviclular fluid, mouthrinse and saliva for monitoring periodontal diseases. Periodontol. 2000 2016, 70,
142–163. [CrossRef] [PubMed]
14. Sorsa, T.; Gieselmann, D.; Arweiler, N.B.; Hernandez, M. A quantitative point-of-care test for periodontal
and dental peri-implant diseases. Nat. Rev. Dis. Primers 2017, 3, 17069. [CrossRef] [PubMed]
15. Kuula, H.; Salo, T.; Pirila, E.; Tuomainen, A.M.; Jauhiainen, M.; Uitto, V.J.; Tjaderhane, L.; Pussinen, P.J.;
Sorsa, T. Local and systemic responses in matrix metalloproteinase 8-deficient mice during porphyromonas
gingivalis-induced periodontitis. Infect. Immun. 2009, 77, 850–859. [CrossRef] [PubMed]
16. Abe, M.; Kawamoto, K.; Okamoto, H.; Horiuchi, N. Induction of collagenase-2 (matrix metalloproteinase–8)
gene expression by interleukin-1beta in human gingival fibroblasts. J. Periodontal. Res. 2001, 36, 153–159.
[CrossRef] [PubMed]
17. Hanemaaijer, R.; Sorsa, T.; Konttinen, Y.T.; Ding, Y.; Sutinen, M.; Visser, H.; van Hinsbergh, V.W.;
Helaakoski, T.; Kainulainen, T.; Ronka, H.; et al. Matrix metalloproteinase-8 is expressed in rheumatoid
synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J. Biol.
Chem. 1997, 272, 31504–31509. [CrossRef] [PubMed]
18. Sorsa, T.; Tjaderhane, L.; Konttinen, Y.T.; Lauhio, A.; Salo, T.; Lee, H.M.; Golub, L.M.; Brown, D.L.;
Mantyla, P. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis and treatment of periodontal
inflammation. Ann. Med. 2006, 38, 306–321. [CrossRef] [PubMed]
19. Baeza, M.; Garrido, M.; Hernandez–Rios, P.; Dezerega, A.; Garcia-Sesnich, J.; Strauss, F.; Aitken, J.P.;
Lesaffre, E.; Vanbelle, S.; Gamonal, J.; et al. Diagnostic accuracy for apical and chronic periodontitis
biomarkers in gingival crevicular fluid: An exploratory study. J. Clin. Periodontol. 2016, 43, 34–45. [CrossRef]
[PubMed]
20. Harjunmaa, U.; Jarnstedt, J.; Alho, L.; Dewey, K.G.; Cheung, Y.B.; Deitchler, M.; Ashorn, U.; Maleta, K.;
Klein, N.J.; Ashorn, P. Association between maternal dental periapical infections and pregnancy outcomes:
Results from a cross-sectional study in Malawi. Trop. Med. Int. Health 2015, 20, 1549–1558. [CrossRef]
[PubMed]
Diagnostics 2018, 8, 67 14 of 15
21. Ainamo, J.; Barmes, D.; Beagrie, G.; Cutress, T.; Martin, J.; Sardo-Infirri, J. Development of the world health
organization (who) community periodontal index of treatment needs (cpitn). Int. Dent. J. 1982, 32, 281–291.
[PubMed]
22. Khocht, A.; Zohn, H.; Deasy, M.; Chang, K.M. Screening for periodontal disease: Radiographs vs. Psr. J. Am.
Dent. Assoc. 1996, 127, 749–756. [CrossRef] [PubMed]
23. Khocht, A.; Zohn, H.; Deasy, M.; Chang, K.M. Assessment of periodontal status with psr and traditional
clinical periodontal examination. J. Am. Dent. Assoc. 1995, 126, 1658–1665. [CrossRef] [PubMed]
24. Ziebolz, D.; Szabadi, I.; Rinke, S.; Hornecker, E.; Mausberg, R.F. Initial periodontal screening and radiographic
findings—A comparison of two methods to evaluate the periodontal situation. BMC Oral Health 2011, 11, 3.
[CrossRef] [PubMed]
25. Schatzle, M.; Faddy, M.J.; Cullinan, M.P.; Seymour, G.J.; Lang, N.P.; Burgin, W.; Anerud, A.; Boysen, H.;
Loe, H. The clinical course of chronic periodontitis: V. Predictive factors in periodontal disease. J. Clin.
Periodontol. 2009, 36, 365–371. [CrossRef] [PubMed]
26. Matuliene, G.; Pjetursson, B.E.; Salvi, G.E.; Schmidlin, K.; Bragger, U.; Zwahlen, M.; Lang, N.P. Influence of
residual pockets on progression of periodontitis and tooth loss: Results after 11 years of maintenance. J. Clin.
Periodontol. 2008, 35, 685–695. [CrossRef] [PubMed]
27. Eke, P.I.; Page, R.C.; Wei, L.; Thornton-Evans, G.; Genco, R.J. Update of the case definitions for
population-based surveillance of periodontitis. J. Periodontol. 2012, 83, 1449–1454. [CrossRef] [PubMed]
28. Graetz, C.; Plaumann, A.; Wiebe, J.F.; Springer, C.; Salzer, S.; Dorfer, C.E. Periodontal probing versus
radiographs for the diagnosis of furcation involvement. J. Periodontol. 2014, 85, 1371–1379. [CrossRef]
[PubMed]
29. Chapple, I.L.C.; Mealey, B.L.; Van Dyke, T.E.; Bartold, P.M.; Dommisch, H.; Eickholz, P.; Geisinger, M.L.;
Genco, R.J.; Glogauer, M.; Goldstein, M.; et al. Periodontal health and gingival diseases and conditions on
an intact and a reduced periodontium: Consensus report of workgroup 1 of the 2017 world workshop on
the classification of periodontal and peri-implant diseases and conditions. J. Periodontol. 2018, 45, S68–S77.
[CrossRef] [PubMed]
30. Papapanou, P.N.; Sanz, M.; Buduneli, N.; Dietrich, T.; Feres, M.; Fine, D.H.; Flemmig, T.F.; Garcia, R.;
Giannobile, W.V.; Graziani, F.; et al. Periodontitis: Consensus report of workgroup 2 of the 2017 world
workshop on the classification of periodontal and peri–implant diseases and conditions. J. Periodontol. 2018,
89, S173–S182. [CrossRef] [PubMed]
31. Kiili, M.; Cox, S.W.; Chen, H.Y.; Wahlgren, J.; Maisi, P.; Eley, B.M.; Salo, T.; Sorsa, T. Collagenase-2 (mmp-8)
and collagenase-3 (mmp-13) in adult periodontitis: Molecular forms and levels in gingival crevicular fluid
and immunolocalisation in gingival tissue. J. Clin. Periodontol. 2002, 29, 224–232. [CrossRef] [PubMed]
32. Lee, W.; Aitken, S.; Sodek, J.; McCulloch, C.A. Evidence of a direct relationship between neutrophil
collagenase activity and periodontal tissue destruction in vivo: Role of active enzyme in human periodontitis.
J. Periodontal. Res. 1995, 30, 23–33. [CrossRef] [PubMed]
33. Baelum, V.; Scheutz, F. Periodontal diseases in Africa. Periodontol. 2000 2002, 29, 79–103. [CrossRef] [PubMed]
34. Kassebaum, N.J.; Bernabe, E.; Dahiya, M.; Bhandari, B.; Murray, C.J.; Marcenes, W. Global burden of severe
periodontitis in 1990–2010: A systematic review and meta-regression. J. Dent. Res. 2014, 93, 1045–1053.
[CrossRef] [PubMed]
35. Mellanen, L.; Lahdevirta, J.; Tervahartiala, T.; Meurman, J.H.; Sorsa, T. Matrix metalloproteinase-7, -8, -9,
-25, and -26 and cd43, -45, and -68 cell-markers in hiv-infected patients′ saliva and gingival tissue. J. Oral
Pathol. Med. 2006, 35, 530–539. [CrossRef] [PubMed]
36. Nylund, K.M.; Meurman, J.H.; Heikkinen, A.M.; Honkanen, E.; Vesterinen, M.; Furuholm, J.O.;
Tervahartiala, T.; Sorsa, T.; Ruokonen, H.M. Periodontal inflammatory burden and salivary matrix
metalloproteinase-8 concentration among patients with chronic kidney disease at the predialysis stage.
J. Periodontol. 2015, 86, 1212–1220. [CrossRef] [PubMed]
37. Kormi, I.; Nieminen, M.T.; Havulinna, A.S.; Zeller, T.; Blankenberg, S.; Tervahartiala, T.; Sorsa, T.; Salomaa, V.;
Pussinen, P.J. Matrix metalloproteinase-8 and tissue inhibitor of matrix metalloproteinase-1 predict incident
cardiovascular disease events and all-cause mortality in a population-based cohort. Eur. J. Prev. Cardiol.
2017, 24, 1136–1144. [CrossRef] [PubMed]
Diagnostics 2018, 8, 67 15 of 15
38. Liljestrand, J.M.; Mantyla, P.; Paju, S.; Buhlin, K.; Kopra, K.A.; Persson, G.R.; Hernandez, M.; Nieminen, M.S.;
Sinisalo, J.; Tjaderhane, L.; et al. Association of endodontic lesions with coronary artery disease. J. Dent. Res.
2016, 95, 1358–1365. [CrossRef] [PubMed]
39. Schaefer, A.S.; Richter, G.M.; Groessner-Schreiber, B.; Noack, B.; Nothnagel, M.; El Mokhtari, N.E.; Loos, B.G.;
Jepsen, S.; Schreiber, S. Identification of a shared genetic susceptibility locus for coronary heart disease and
periodontitis. PLoS Genet. 2009, 5, e1000378. [CrossRef] [PubMed]
40. Lopez, R.; Smith, P.C.; Gostemeyer, G.; Schwendicke, F. Ageing, dental caries and periodontal diseases.
J. Clin. Periodontol. 2017, 44, S145–S152. [CrossRef] [PubMed]
41. Holtfreter, B.; Albandar, J.M.; Dietrich, T.; Dye, B.A.; Eaton, K.A.; Eke, P.I.; Papapanou, P.N.; Kocher, T.
Standards for reporting chronic periodontitis prevalence and severity in epidemiologic studies: Proposed
standards from the joint EU/USA periodontal epidemiology working group. J. Clin. Periodontol. 2015, 42,
407–412. [CrossRef] [PubMed]
© 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
